Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 217

    1.

    A role for advanced glycation end products in diminished bone healing in type 1 diabetes.

    Santana RB, Xu L, Chase HB, Amar S, Graves DT, Trackman PC.

    Diabetes. 2003 Jun;52(6):1502-10.PMID: 12765963 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury.

    Soulis T, Thallas V, Youssef S, Gilbert RE, McWilliam BG, Murray-McIntosh RP, Cooper ME.

    Diabetologia. 1997 Jun;40(6):619-28.PMID: 9222639 [PubMed - indexed for MEDLINE]Related articles

    3.

    Advanced glycation end products and receptor for advanced glycation end products in AA amyloidosis.

    Röcken C, Kientsch-Engel R, Mansfeld S, Stix B, Stubenrauch K, Weigle B, Bühling F, Schwan M, Saeger W.

    Am J Pathol. 2003 Apr;162(4):1213-20.PMID: 12651613 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Gene expression of receptor for advanced glycosylation end products and its modulation by aminoguanidine in diabetic kidney tissue.

    Huang Y, Lin S, Zhou J.

    Chin Med J (Engl). 1998 Aug;111(8):698-704.PMID: 11245022 [PubMed - indexed for MEDLINE]Related articles

    5.

    Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease.

    Tanji N, Markowitz GS, Fu C, Kislinger T, Taguchi A, Pischetsrieder M, Stern D, Schmidt AM, D'Agati VD.

    J Am Soc Nephrol. 2000 Sep;11(9):1656-66.PMID: 10966490 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes.

    Shoji T, Koyama H, Morioka T, Tanaka S, Kizu A, Motoyama K, Mori K, Fukumoto S, Shioi A, Shimogaito N, Takeuchi M, Yamamoto Y, Yonekura H, Yamamoto H, Nishizawa Y.

    Diabetes. 2006 Aug;55(8):2245-55.PMID: 16873687 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Advanced glycation endproducts influence the mRNA expression of RAGE, RANKL and various osteoblastic genes in human osteoblasts.

    Franke S, Siggelkow H, Wolf G, Hein G.

    Arch Physiol Biochem. 2007 Jun;113(3):154-61.PMID: 17922311 [PubMed - indexed for MEDLINE]Related articles

    8.

    Advanced glycation end-products (AGEs) induce concerted changes in the osteoblastic expression of their receptor RAGE and in the activation of extracellular signal-regulated kinases (ERK).

    Cortizo AM, Lettieri MG, Barrio DA, Mercer N, Etcheverry SB, McCarthy AD.

    Mol Cell Biochem. 2003 Aug;250(1-2):1-10.PMID: 12962137 [PubMed - indexed for MEDLINE]Related articles

    9.

    Inhibitors of advanced glycation end-products prevent loss of enteric neuronal nitric oxide synthase in diabetic rats.

    Jeyabal PV, Kumar R, Gangula PR, Micci MA, Pasricha PJ.

    Neurogastroenterol Motil. 2008 Mar;20(3):253-61. Epub 2007 Oct 17.PMID: 17971026 [PubMed - indexed for MEDLINE]Related articles

    10.

    Candesartan reduced advanced glycation end-products accumulation and diminished nitro-oxidative stress in type 2 diabetic KK/Ta mice.

    Fan Q, Liao J, Kobayashi M, Yamashita M, Gu L, Gohda T, Suzuki Y, Wang LN, Horikoshi S, Tomino Y.

    Nephrol Dial Transplant. 2004 Dec;19(12):3012-20.PMID: 15574998 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways.

    Alikhani M, Alikhani Z, Boyd C, MacLellan CM, Raptis M, Liu R, Pischon N, Trackman PC, Gerstenfeld L, Graves DT.

    Bone. 2007 Feb;40(2):345-53. Epub 2006 Oct 24.PMID: 17064973 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    AGE/RAGE produces endothelial dysfunction in coronary arterioles in type 2 diabetic mice.

    Gao X, Zhang H, Schmidt AM, Zhang C.

    Am J Physiol Heart Circ Physiol. 2008 Aug;295(2):H491-8. Epub 2008 Jun 6.PMID: 18539754 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Differential effects between amphoterin and advanced glycation end products on colon cancer cells.

    Kuniyasu H, Chihara Y, Kondo H.

    Int J Cancer. 2003 May 10;104(6):722-7.PMID: 12640679 [PubMed - indexed for MEDLINE]Related articles

    15.

    The combination of high glucose and advanced glycation end-products (AGEs) inhibits the mineralization of osteoblastic MC3T3-E1 cells through glucose-induced increase in the receptor for AGEs.

    Ogawa N, Yamaguchi T, Yano S, Yamauchi M, Yamamoto M, Sugimoto T.

    Horm Metab Res. 2007 Dec;39(12):871-5. Epub 2007 Oct 24.PMID: 17960513 [PubMed - indexed for MEDLINE]Related articles

    16.

    Receptor for advanced glycation end products (RAGEs) and experimental diabetic neuropathy.

    Toth C, Rong LL, Yang C, Martinez J, Song F, Ramji N, Brussee V, Liu W, Durand J, Nguyen MD, Schmidt AM, Zochodne DW.

    Diabetes. 2008 Apr;57(4):1002-17. Epub 2007 Nov 26.PMID: 18039814 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression.

    Kislinger T, Fu C, Huber B, Qu W, Taguchi A, Du Yan S, Hofmann M, Yan SF, Pischetsrieder M, Stern D, Schmidt AM.

    J Biol Chem. 1999 Oct 29;274(44):31740-9.PMID: 10531386 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Upregulation of the ligand-RAGE pathway via the angiotensin II type I receptor is essential in the pathogenesis of diabetic atherosclerosis.

    Ihara Y, Egashira K, Nakano K, Ohtani K, Kubo M, Koga J, Iwai M, Horiuchi M, Gang Z, Yamagishi S, Sunagawa K.

    J Mol Cell Cardiol. 2007 Oct;43(4):455-64. Epub 2007 Jul 21.PMID: 17761193 [PubMed - indexed for MEDLINE]Related articles

    19.

    Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics.

    Valencia JV, Weldon SC, Quinn D, Kiers GH, DeGroot J, TeKoppele JM, Hughes TE.

    Anal Biochem. 2004 Jan 1;324(1):68-78.PMID: 14654047 [PubMed - indexed for MEDLINE]Related articles

    20.

    Identification of mouse orthologue of endogenous secretory receptor for advanced glycation end-products: structure, function and expression.

    Harashima A, Yamamoto Y, Cheng C, Tsuneyama K, Myint KM, Takeuchi A, Yoshimura K, Li H, Watanabe T, Takasawa S, Okamoto H, Yonekura H, Yamamoto H.

    Biochem J. 2006 May 15;396(1):109-15.PMID: 16503878 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data